Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (15)

2024

  1. Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

    Journal of Psychiatric Research, Vol. 172, pp. 334-339

2023

  1. Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up

    International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807

2022

  1. The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance

    The international journal of neuropsychopharmacology, Vol. 25, Núm. 8, pp. 666-677

2021

  1. Periodontal diseases and depression: A pre-clinical in vivo study

    Journal of Clinical Periodontology, Vol. 48, Núm. 4, pp. 503-527

2019

  1. Differences in the regulation of inflammatory pathways in adolescent- and adult-onset first-episode psychosis

    European Child and Adolescent Psychiatry, Vol. 28, Núm. 10, pp. 1395-1405

2016

  1. BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year

    Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151

  2. Cognition and psychopathology in first-episode psychosis: Are they related to inflammation?

    Psychological Medicine, Vol. 46, Núm. 10, pp. 2133-2144

  3. Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis

    Journal of Psychiatric Research, Vol. 75, pp. 14-21

2015

  1. Pro-/antiinflammatory dysregulation in early psychosis: Results from a 1-year follow-Up study

    International Journal of Neuropsychopharmacology, Vol. 18, Núm. 2, pp. 1-10

2014

  1. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: Toward an integrative inflammatory hypothesis of schizophrenia

    Schizophrenia Bulletin, Vol. 40, Núm. 2, pp. 376-387

2013

  1. Peripheral endocannabinoid system dysregulation in first-episode psychosis

    Neuropsychopharmacology, Vol. 38, Núm. 13, pp. 2568-2577

  2. Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation

    International Journal of Neuropsychopharmacology, Vol. 16, Núm. 1, pp. 121-135

2012

  1. Endogenous cannabinoid system regulates intestinal barrier function in vivo through cannabinoid type 1 receptor activation

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 302, Núm. 5

2010

  1. Anti-inflammatory effects of Mangifera indica L. extract in a model of colitis

    World Journal of Gastroenterology, Vol. 16, Núm. 39, pp. 4922-4931

2009

  1. Colonic bacterial translocation as a possible factor in stress-worsening experimental stroke outcome

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 296, Núm. 4